Company news
Inotiv, Inc. (NASDAQ:NOTV) news
Inotiv, Inc. news releases on 6ix. Latest, Feb 1, 2023: Inotiv Selected as a Winner of the 2023 Top Workplaces USA Award
Press releases — page 2
Inotiv Selected as a Winner of the 2023 Top Workplaces USA Award
January 31, 2023
Inotiv, Inc. Announces Changes to Board of Directors
January 22, 2023
Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2022 Financial Results
January 9, 2023
Inotiv, Inc. Provides Business Update and Select Preliminary Fiscal Year 2022 Financial Results
December 11, 2022
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 7, 2022
Inotiv, Inc. Announces Additional Site Consolidation Plan in the U.S., Intent to Consult with Employee Representatives for a Proposed Consolidation of Certain European and U.K. Sites, and Update on Site Optimization Plans in Process
November 28, 2022
Inotiv, Inc. to Report Fourth Quarter Fiscal 2022 Financial Results and Host Conference Call on Monday, December 12, 2022
November 27, 2022
Inotiv, Inc. Announces Third Quarter Fiscal 2022 Financial Results
August 9, 2022
Inotiv, Inc. Continues to Expand Genetic Toxicology Offering with Support of GLP Assays at Rockville, MD, Location
July 25, 2022
Inotiv, Inc. Expands Protein/Peptide Bioanalytical Capabilities with Acquisition of Protypia, Inc.
July 6, 2022
Glenn Washer Joins Inotiv, Inc., as Group President, Safety Assessment
June 21, 2022
Inotiv, Inc. Announces Site Closures and Consolidation Plans
June 12, 2022
Inotiv, Inc. Announces Second Quarter Fiscal 2022 Financial Results
May 11, 2022
Inotiv, Inc. Bolsters Pathology Services with Acquisition of Histion, LLC
April 24, 2022
Inotiv, Inc. Announces First Quarter Fiscal 2022 Financial Results
February 9, 2022
Inotiv, Inc. Announces Expansion of Non-Human Primate Facilities and Services with Acquisition of Orient BioResource Center, Inc.
January 26, 2022
Inotiv, Inc. Announces Expansion of Safety Assessment Offerings with Acquisition of Integrated Laboratory Systems, LLC
January 9, 2022
Inotiv, Inc. Announces the Acquisition of the Rabbit Breeding and Supply Business of Robinson Services Inc. (“RSI”)
January 5, 2022
Inotiv, Inc. and Synexa Life Sciences Sign Letter of Intent to Establish Center of Excellence for Biotherapeutics and Biomarkers
January 3, 2022
Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2021 Financial Results
December 15, 2021
Inotiv, Inc. Reschedules Fourth Quarter Fiscal 2021 Financial Results and Conference Call for Thursday, December 16, 2021
December 12, 2021
Inotiv, Inc. Announces the Launch of New Genetically Engineered Rodent Models for SARS-CoV-2 (COVID-19) Research
December 12, 2021
Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for the Fourth Quarter and Full Year Fiscal 2021
December 6, 2021
Inotiv, Inc. to Report Fourth Quarter Fiscal 2021 Financial Results and Host Conference Call on Tuesday, December 7, 2021
November 28, 2021
Inotiv, Inc. Announces Opening of Newly-Constructed Laboratories at St. Louis Facility
November 9, 2021
Inotiv, Inc. Completes Purchase of Envigo
November 4, 2021
Inotiv, Inc. Shareholders Approve Acquisition of Envigo
November 3, 2021
Inotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc.
October 3, 2021
Inotiv, Inc. Announces Closing of $125 Million Convertible Senior Notes Offering and Full Exercise of Option to Purchase Additional $15 Million of Notes
September 26, 2021
Inotiv, Inc. Prices Upsized $125 Million Convertible Senior Notes Offering
September 21, 2021
Inotiv, Inc. Announces Proposed Convertible Senior Notes Offering
September 20, 2021
Inotiv, Inc. Announces Third Quarter Fiscal 2021 Financial Results
August 10, 2021
Inotiv, Inc. Announces Acquisition of Gateway Pharmacology Laboratories
August 1, 2021
Inotiv, Inc. to Report Third Quarter Fiscal 2021 Financial Results and Host Conference Call on Wednesday, August 11, 2021
July 21, 2021
Inotiv Acquires Laboratory Instrumentation for Discovery and Development of Novel Therapies
July 14, 2021
Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma’s BioReliance® portfolio
July 11, 2021
Inotiv, Inc. Broadens Pathology Services to Include Medical Device Pathology and Hires Nicolette Jackson to Lead Effort
June 27, 2021
Inotiv Announces Purchase of St. Louis Facility and Plans to Expand Capacity
May 26, 2021
Kenneth Swart, Ph.D., Joins Inotiv as Vice President, Bioanalytical Sciences to Drive Growth of Expanding Laboratory Solutions Offerings
May 10, 2021
Inotiv, Inc. Announces Second Quarter Fiscal 2021 Financial Results
May 4, 2021
Inotiv, Inc. Announces Debt Financing and Completion of Acquisitions of HistoTox Labs, Inc. and Bolder BioPATH, Inc.
April 29, 2021
Inotiv, Inc. Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Shares
April 22, 2021
Inotiv, Inc. Announces Pricing of Public Offering of 2,647,059 Common Shares
April 20, 2021
Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for Second Quarter and Year to Date Fiscal 2021
April 19, 2021
Inotiv, Inc. Announces Proposed Public Offering of Common Shares
April 19, 2021
Inotiv, Inc. Announces Plan to Expand the Company’s Internal Operations
April 18, 2021
Inotiv, Inc. Announces Expansion of Pharmacology and Pathology Offerings with Agreement to Purchase Bolder BioPATH, Inc.
April 15, 2021
Inotiv, Inc. Enhances Histopathology Offering with Announcement of Agreement to Purchase HistoTox Labs, Inc.
April 12, 2021
Inotiv, Inc. Announces Partnership with PhoenixBio Co., Ltd. to Expand Discovery Pharmacology Offering
April 5, 2021
Bioanalytical Systems, Inc., doing business as Inotiv, Announces Plan to Expand Service Offerings to Include Cardiovascular Safety Pharmacology
March 16, 2021